323 filings
Page 4 of 17
8-K
vxk 8btqv
15 Oct 21
Entry into a Material Definitive Agreement
5:05pm
8-K
ropbzt
6 Oct 21
Skye Bioscience Appoints Kaitlyn Arsenault as Chief Financial Officer
12:00am
8-K
s357e
30 Sep 21
Skye Bioscience Announces Closing of $7.0 Million Registered Direct Offering
12:00am
8-K
2pbi oe6bna0q3tt
28 Sep 21
Skye Bioscience Announces $7.0 Million Registered Direct Offering
8:45am
424B5
bdwn82v4e0bxkagl
28 Sep 21
Prospectus supplement for primary offering
8:30am
8-K
amzdibn217
15 Sep 21
Departure of Directors or Certain Officers
12:00am
EFFECT
s1mx iv5wgg
10 Aug 21
Notice of effectiveness
12:15am
424B3
5iz10y2x 8p8
5 Aug 21
Prospectus supplement
9:43pm
CORRESP
81n8a1e
5 Aug 21
Correspondence with SEC
12:00am
UPLOAD
sqmy47j8g1 a6ndn
4 Aug 21
Letter from SEC
12:00am
S-3
5f7zkr7m962j8cl
29 Jul 21
Shelf registration
12:00am
8-K
h8m8 452z
26 Jul 21
Skye Bioscience Appoints Biotech Executive
12:40pm
8-K
t76d24u5a86zj7 xv7
22 Jul 21
Entry into a Material Definitive Agreement
8:00am
424B3
9kn5mmcun1jtsvr eoa
7 May 21
Prospectus supplement
8:03am
424B3
ye03m44gfkms9hpwlkw5
2 Mar 21
Prospectus supplement
12:00am
8-K
vrrbu9b j8
3 Feb 21
Submission of Matters to a Vote of Security Holders
5:16pm
8-K
e8yyw8etjku7hl
19 Jan 21
Amendments to Articles of Incorporation or Bylaws
10:57am